Federated Hermes’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-220,000
| Closed | -$47.7M | – | 2410 |
|
|
2021
Q1 | $47.7M | Sell |
220,000
-503,715
| -70% | -$94.7M | 0.09% | 276 |
|
|
2020
Q4 | $83.5M | Sell |
723,715
-138,029
| -16% | -$15.5M | 0.17% | 153 |
|
|
2020
Q3 | $83.9M | Buy |
861,744
+38,344
| +5% | +$4.41M | 0.2% | 126 |
|
|
2020
Q2 | $101M | Buy |
823,400
+69,968
| +9% | +$7.94M | 0.25% | 96 |
|
|
2020
Q1 | $66M | Buy |
753,432
+429,032
| +132% | +$45.4M | 0.19% | 119 |
|
|
2019
Q4 | $33.9M | Buy |
324,400
+37,610
| +13% | +$4.22M | 0.08% | 286 |
|
|
2019
Q3 | $33M | Sell |
286,790
-18,410
| -6% | -$2.79M | 0.08% | 253 |
|
|
2019
Q2 | $52.6M | Sell |
305,200
-112,550
| -27% | -$19.5M | 0.13% | 181 |
|
|
2019
Q1 | $70.4M | Buy |
417,750
+79,367
| +23% | +$11.8M | 0.17% | 124 |
|
|
2018
Q4 | $33M | Buy |
338,383
+81,083
| +32% | +$10.6M | 0.09% | 234 |
|
|
2018
Q3 | $44.4M | Buy |
257,300
+32,000
| +14% | +$4.61M | 0.1% | 210 |
|
|
2018
Q2 | $31.4M | Sell |
225,300
-72,900
| -24% | -$10.4M | 0.09% | 182 |
|
|
2018
Q1 | $33.6M | Hold |
298,200
| – | – | 0.1% | 177 |
|
|
2017
Q4 | $39.4M | Buy |
298,200
+46,100
| +18% | +$5.42M | 0.11% | 153 |
|
|
2017
Q3 | $25.6M | Sell |
252,100
-7,900
| -3% | -$846K | 0.07% | 222 |
|
|
2017
Q2 | $26.1M | Hold |
260,000
| – | – | 0.08% | 228 |
|
|
2017
Q1 | $31.4M | Buy |
260,000
+18,400
| +8% | +$2.26M | 0.09% | 198 |
|
|
2016
Q4 | $27M | Sell |
241,600
-46,080
| -16% | -$5.55M | 0.08% | 213 |
|
|
2016
Q3 | $38.2M | Sell |
287,680
-213,320
| -43% | -$20.4M | 0.11% | 147 |
|
|
2016
Q2 | $45.9M | Hold |
501,000
| – | – | 0.13% | 128 |
|
|
2016
Q1 | $36.1M | Buy |
501,000
+158,300
| +46% | +$8.68M | 0.11% | 159 |
|
|
2015
Q4 | $23.8M | Sell |
342,700
-247,500
| -42% | -$20.2M | 0.08% | 246 |
|
|
2015
Q3 | $53.9M | Sell |
590,200
-265,000
| -31% | -$29.5M | 0.17% | 119 |
|
|
2015
Q2 | $105M | Buy |
855,200
+351,000
| +70% | +$39.8M | 0.32% | 59 |
|
|
2015
Q1 | $45.9M | Sell |
504,200
-42,600
| -8% | -$3.46M | 0.14% | 153 |
|
|
2014
Q4 | $37M | Sell |
546,800
-41,008
| -7% | -$3M | 0.11% | 168 |
|
|
2014
Q3 | $47.5M | Buy |
587,808
+186,294
| +46% | +$16.5M | 0.15% | 126 |
|
|
2014
Q2 | $43.1M | Buy |
401,514
+73,700
| +22% | +$5.12M | 0.14% | 144 |
|
|
2014
Q1 | $19.5M | Buy |
+327,814
| New | +$19.5M | 0.07% | 286 |
|
Other funds holding GWPH
Federated Hermes's GWPH Position: Q2 2021 in Review
Federated Hermes sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 220,000 shares — an estimated $47.7M sold.
Federated Hermes first reported a position in GWPH in Q1 2014 and held it in 29 quarters. The position peaked at $105M in Q2 2015. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Federated Hermes reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Federated Hermes sold 220,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $47.7M.
- Federated Hermes first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2014 and held it in 29 quarters.
- Federated Hermes's GW Pharmaceuticals Plc American Depositary Shares position peaked at $105M in Q2 2015.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Federated Hermes's 13F filing for Q2 2021, filed 16 Aug 2021.